For the quarter ending 2025-12-31, MKZR had -$463,829 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net loss | -4,474,841 | -3,046,894 | -23,970,277 |
| Net unrealized (gain) loss on equity securities at fair value | 184,525 | 1,104,493 | 49,407 |
| Net unrealized gain on securities sold, not yet purchased, at fair value | - | 4,228 | - |
| Net loss from equity method investments at fair value | -77,613 | -27,086 | -767,066 |
| Net realized (gain) loss on investments | 82,063 | -703,907 | 132,434 |
| Impairment loss | 0 | 0 | 9,500,167 |
| Straight-line rent | 40,012 | 33,814 | 154,952 |
| Depreciation and amortization | 2,672,175 | 2,197,528 | 11,432,557 |
| Amortization of deferred financing costs and debt mark-to-market | -470,127 | -217,590 | 1,377,272 |
| Accretion of above (below) market lease, net | -56,975 | -22,486 | -544,103 |
| Stock-based compensation | 0 | -37,363 | 628,137 |
| Investments income, rents and other receivables | -190,524 | -125,530 | 890,103 |
| Due from related entities | - | - | 0 |
| Prepaid expenses and other assets | 63,575 | -11,261 | -125,104 |
| Deferred rent and other liabilities | 529,589 | -227,593 | 50,398 |
| Accounts payable and accrued liabilities | -613,519 | -815,382 | 144,376 |
| Due to related entities | 2,136 | -10,203 | 26,097 |
| Net cash from operating activities | -1,569,118 | -2,019,554 | -1,690,102 |
| Proceeds from sale of investments | - | 699,622 | 962,721 |
| Proceeds from sale of investments | 1,392,012 | 305,348 | - |
| Investments in real estate assets | 2,630,894 | 4,717,178 | 18,899,433 |
| Purchase of investments | 56,595 | 503,225 | 1,183,597 |
| Return of capital distributions | - | - | 0 |
| Payment on contingent liability | - | - | 0 |
| Net cash from investing activities | -1,995,099 | -4,215,433 | -19,120,309 |
| Borrowing under mortgage notes payable | 9,940,992 | - | - |
| Proceeds from mortgage notes payable | -6,707,599 | 6,707,599 | 48,477,670 |
| Payments on mortgage notes payable | 308,556 | 368,188 | 48,876,780 |
| Borrowing under line of credit | 0 | 412,000 | 9,588,000 |
| Proceeds from notes payable | 58,935 | 629,514 | 1,115,000 |
| Payments on notes payable | 105,588 | 6,742 | 223,898 |
| Payment of financing fees | 88,708 | 137,593 | 2,321,155 |
| Dividends to common stockholders | 0 | 0 | 4,802,866 |
| Dividends to preferred stockholders-Series APreferred Stock | 239,649 | 233,759 | 952,669 |
| Dividends to preferred stockholders-Series BPreferred Stock | 15,190 | 14,937 | 40,449 |
| Dividends to preferred stockholders-Series CPreferred Stock | 6,465 | - | - |
| Proceeds from issuance of preferred stock-Series APreferred Stock | 67,635 | 31,000 | 226,100 |
| Proceeds from issuance of preferred stock-Series BPreferred Stock | 90,550 | 102,511 | 1,647,579 |
| Proceeds from issuance of common stock | - | - | 3,794,260 |
| Proceeds from issuance of common stock warrants-Series CPreferred Stock | 386,000 | 688,000 | - |
| Proceeds from issuance of common stock | 139,406 | 172,455 | 1,935,455 |
| Proceeds from issuance of common stock warrants-Common Class A | - | - | 376,268 |
| Proceeds from issuance of common stock warrants-Common Class B | - | - | 223,409 |
| Payment on finance lease liabilities | 67,816 | 66,420 | 234,109 |
| Payment of deferred offering costs | 0 | - | - |
| Payment of selling commissions and fees | 100,956 | 120,902 | 1,876,917 |
| Contributions by non-controlling interests holders | 0 | 0 | 5,574,804 |
| Distributions to non-controlling interests holders | 380,922 | 382,173 | 1,491,165 |
| Redemptions of common stock | 0 | 1,785 | 24 |
| Redemptions of preferred stock-Series APreferred Stock | 27 | 11 | 5,531 |
| Redemptions of preferred stock-Series BPreferred Stock | 4 | - | - |
| Capital pending acceptance | 416,928 | 10,711 | 283,589 |
| Net cash from financing activities | 3,100,388 | 7,399,858 | 11,849,393 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -463,829 | 1,164,871 | -8,961,018 |
| Cash and cash equivalents at beginning of period | 5,281,192 | 4,116,321 | 13,077,339 |
| Cash and cash equivalents at end of period | 4,817,363 | 5,281,192 | 4,116,321 |
MacKenzie Realty Capital, Inc. (MKZR)
MacKenzie Realty Capital, Inc. (MKZR)